Specialty Pharma Journal Specialty, Precision & Technology
GHENT, Belgium, 20 July 2017 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that …
Read More »Ablynx and Sanofi Partner to Develop Nanobody-Based Therapeutics for Inflammatory Diseases
Recent Posts
FDA Grants Orphan Drug Designation to Astellas’ Gilteritinib for Treatment of Acute Myeloid Leukemia
TOKYO, July 20, 2017 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko …
Read More »Takeda and Schrödinger Enter Multi-Target Research Collaboration
OSAKA, Japan & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) and Schrödinger Inc., a …
Read More »Kite’s CAR-T Cell Therapy Demonstrates Positive Results in Patients with Chemorefractory Aggressive NHL
SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc. (Nasdaq:KITE), a leading cell therapy company, highlighted the recent online …
Read More »CDC Report Finds More than 100 Million Americans have Diabetes or Prediabetes
ATLANTA, July 18, 2017 /PRNewswire-USNewswire/ — More than 100 million U.S. adults are now living …
Read More »Vertex Announces Positive Results for Cystic Fibrosis Triple Combos
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive data from Phase 1 and Phase 2 …
Read More »Shire Enters Bispecific Hemophilia Research and Development Deal with Novimmune
Lexington, MA – July 18, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG), the biotech leader …
Read More »FDA Approves Gilead’s Vosevi for Re-Treatment of Adults with Hepatitis C
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and …
Read More »FDA Approves Puma’s Nerlynx for Early Stage HER2-Positive Breast Cancer
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI) today announced that the U.S. Food and Drug …
Read More »FDA Rejects Amgen’s Romosozumab for Treatment of Postmenopausal Women with Osteoporosis
THOUSAND OAKS, Calif. and BRUSSELS, July 16, 2017 /PRNewswire/ — Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. …
Read More »New Imaging Technique Able to Watch Molecular Dynamics of Neurodegenerative Diseases
WASHINGTON — Researchers have developed a fast and practical molecular-scale imaging technique that could let …
Read More »Side Effects Not A Major Problem for New Class of Breast Cancer Drugs
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase …
Read More »New Data Network for Huntington’s Disease Research
Huntington’s disease is an hereditary disorder of the nervous system caused by a faulty gene …
Read More »FDA Committee Recommends Approval of Mylan and Biocon’s Proposed Biosimilar Trastuzumab
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, July 13, 2017/PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE …
Read More »Janssen’s Tremfya Receives FDA Approval for Treatment of Plaque Psoriasis
HORSHAM, Pa., July 13, 2017 /PRNewswire/ — Janssen Biotech, Inc. (Janssen) announced today that the …
Read More »